Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Safety and Immunogenicity Study in Long-term Treatment of Eculizumab (JSC "GENERIUM", Russian Federation)

AO GENERIUM · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
complementsystemimmunogenicityprosafety
paroxysmal nocturnal hemoglobinuria, eculizumab, humanized monoclonal antibodies, safety, rare disease, biosimilar, complement system, c5 component of complement, pro-inflammatory cytokines, membrane attack complex (mac), immunogenicity, interventional
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 848225
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.